Contemporary role of postoperative radiotherapy for prostate cancer

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


While radical prostatectomy (RP) has provided long-term disease control for the majority of patients with localized prostate cancer (CaP), nearly 30% of all surgical patients have disease progression. For high-risk patients, more than half of men experience disease recurrence within 10 years. Postoperative radiotherapy is the only known potentially curative treatment for a large number of patients following prostatectomy. Lately, there have been several advances with the potential to improve outcomes for patients undergoing postoperative radiotherapy. This article will give an overview of the existing literature and current controversies on: (I) timing of postoperative radiation; (II) use of concomitant androgen deprivation therapy; (III) optimal dose to the prostate bed; (IV) use of hypofractionation; (V) elective treatment of the pelvic lymph nodes; (VI) novel imaging modalities, and (VII) genomic biomarkers.

Original languageEnglish (US)
Pages (from-to)399-413
Number of pages15
JournalTranslational Andrology and Urology
Issue number3
StatePublished - Jun 1 2018


  • Adjuvant radiation
  • Postoperative radiotherapy
  • Prostate cancer (CaP)
  • Prostatectomy
  • Salvage radiation

ASJC Scopus subject areas

  • Reproductive Medicine
  • Urology


Dive into the research topics of 'Contemporary role of postoperative radiotherapy for prostate cancer'. Together they form a unique fingerprint.

Cite this